Historical record - last NADAC effective date: 10/19/2022
Product Information
QSYMIA 7.5 MG-46 MG CAPSULE is a brand product labeled by Vivus LLC, priced at $5.9584 per EA under NDC 62541020230. Its NADAC has been published 472 times since Dec 18, 2013.
FDA first approved this application on Jul 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
7.5; 46 mg/1; mg/1
Manufacturer
Vivus LLCNDC
62541020230
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
10/19/2022
Active Ingredients
PHENTERMINE HYDROCHLORIDE; TOPIRAMATEApproval Type
New Drug (NDA)
FDA Application
NDA022580FDA Approved
7/17/2012
TE Code
AB
On Market Since
9/17/2012
Pharmacological Classes
Price Statistics
The NADAC for QSYMIA 7.5 MG-46 MG CAPSULE has been published 472 times since Dec 18, 2013, and over the history we have for it it has risen 20.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.9584 per EA |
|---|---|
| All-time high | $5.9794 (Apr 13, 2016) |
| All-time low | $4.9415 (Jan 22, 2014) |
| Median price | $5.9520 |
| Average price | $5.8544 |
| Largest weekly change | +11.0% (Apr 9, 2014) |
| Weeks tracked | 472 |
| Tracking since | Dec 18, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
+0.1%
All
+20.4%
Last surveyed Dec 28, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 45% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QSYMIA 7.5 MG-46 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for QSYMIA 7.5 MG-46 MG CAPSULE, manufactured by Vivus LLC, is $5.9584 per EA (NDC 62541020230), effective Dec 28, 2022.
How has the price of QSYMIA 7.5 MG-46 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for QSYMIA 7.5 MG-46 MG CAPSULE has risen 20.4%. It has been tracked across 472 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for QSYMIA 7.5 MG-46 MG CAPSULE?
Since Dec 18, 2013, the NADAC for QSYMIA 7.5 MG-46 MG CAPSULE has ranged from a low of $4.9415 (Jan 22, 2014) to a high of $5.9794 (Apr 13, 2016), with a median of $5.9520 per EA.
Are there cheaper alternatives to QSYMIA 7.5 MG-46 MG CAPSULE?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE, is $3.2920 per EA — about 45% below QSYMIA 7.5 MG-46 MG CAPSULE.
Who manufactures QSYMIA 7.5 MG-46 MG CAPSULE?
QSYMIA 7.5 MG-46 MG CAPSULE (NDC 62541020230) is labeled by Vivus LLC, and CMS classifies it as a brand product.